Moore KN, Oza AM, Colombo N, Oaknin A, et al. Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I. Ann Oncol 2021 Mar 2. pii: S0923-7534(21)00157.
PMID: 33667670